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Impaired energy metabolism in skeletal muscle during phosphate
depletion. The effects of phosphate depletion (PD) of 4, 8, and 12 weeks
on skeletal muscle energy metabolism were studied in rats fed a
phosphate deficiency diet and compared with rats pairfed with a normal
phosphate diet. Skeletal muscle biopsy specimens were examined for
energy production, transport, and utilization. The results show that
already by 4 weeks of PD, the concentration of inorganic phosphorus of
the skeletal muscle was significantly reduced and remained low thereaf-
ter. There was significant (P <0.01) and direct correlation between the
cellular inorganic phosphorus and that of serum phosphorus. Adenine
nucleotides, ATP, ADP, AMP, and creatine phosphate levels did not
change. Mitochondrial respiration and oxidative phosphorylation were
impaired by PD. Total cellular mitochondrial and myofibrillar creatine
phosphokinase activities were significantly reduced at 4 weeks of PD
and fell further at 8 and 12 weeks. There was a significant (P < 0.01) and
direct correlation between the activity of total extractable creatine
phosphokinase and both serum and cellular levels of inorganic phospho-
rus. These data show that chronic PD is associated with a decrease in
energy production, transfer, and utilization by skeletal muscle and
provides information on the molecular events responsible for the
myopathy of PD.
Alteration du metabolisme energetique dans le muscle squellettique
pendant Ia depletion phosphate. Les effets d'une déplétion phosphatée
(PD) pendant 4, 8, et 12 semaines sur le métabolisme energétique du
muscle squelettique ont ëté étudiés chez des rats recevant un régime
deficient en phosphate et compares avec des rats nourris de façon
appariee avec un régime normal en phosphate. Des specimens biopsies
de muscles squelettiques ont été examinées pour Ia production, le
transport, et l'utilisation d'energie. Les résultats indiquent que déjà a 4
semaines de PD, Ia concentration de phosphore inorganique dans le
muscle squelettique était significativement réduite et restait basse
ensuite. II y avait une correlation significative (P < 0.01) et directe entre
le phosphore cellulaire inorganique et le phosphore sérique. Les
niveaux d'adénine nucléotides, ATP, ADP, AMP, et de créatine
phosphate n'ont pas change. La respiration mitochondriale et Ia phos-
phorylation oxydative étaient altérées par Ia PD. Les activités créatine-
phospho-kinase celtulaire totale, mitochondriale et myofibrillaire
étaient significativement réduites a 4 semaines de PD et s'abaissaient
encore a 8 et 12 semaines. Ii y avait une correlation significative (P <
0.01) et directe entre l'activité de Ia creatine-phospho-kinase totale
extractible et a La fois les concentrations de phosphore inorganique
sériques et cellulaires. Ces données indiquent que Ia PD chronique est
associCe a une diminution de Ia production, du transfert et de l'utilisa-
tion d'energie par le muscle squelettique, et elles apportent une
information sur les anomalies moléculàires responsables de Ia myo-
pathie de Ia PD.
mental PD in rats caused muscle weakness and creatinuria.
Lotz, Zisman, and Barter [2] described four patients who
developed severe muscle weakness, with PD. Fuller et al [31
reported muscle weakness, increased total muscle content of
water, significant drop in potassium content, and a fall in total
muscle phosphorus in phosphate-depleted dogs. These changes
were accompanied by a marked fall in resting membrane
potential and were reversible upon repletion with dietary phos-
phorus. We examined the changes in cardiac energy metabo-
lism in PD [4] and mitochondrial energy production and
utilization.
The biochemical events responsible for the skeletal myopa-
thy of PD have not been evaluated in the past and alteration in
cellular energetics may occur during PD and may be responsible
for the derangements in skeletal muscle function. The present
study is an extension of our work in cardiac muscle effects [4] of
early, moderate, and prolonged PD on cellular energy produc-
tion, transfer, and utilization of the skeletal muscle.
Methods
Sprague-Dawley rats, weighing 150 to 200 g, were studied
after 4, 8, and 12 weeks of selective phosphorus depletion
produced by dietary phosphorus restriction. The animals were
fed rat chow containing 0.025% phosphorus. Another group of
weight and age-matched, pairfed rats received diets containing
0.35% phosphorus and served as control. At the day of experi-
ments, rats were anesthetized with an intraperitoneal injection
of 5 mg/kg pentobarbital, intubated, and respirated to maintain
a P02 85 to 80 mm of Hg and Pco2 of 37 to 42 mm Hg. The
anterior thigh muscle was exposed and a biopsy specimen was
taken from the medial aspect of the quadriceps femoris, utiliz-
ing freeze-clamping liquid nitrogen techniques [5]. Blood was
collected for the measurement of serum inorganic phosphorus.
Biopsy specimens were taken from the same muscle site at all
times. The samples were then pulverized with a mortar and
pestle liquid nitrogen as described by Lowry and Passanneau
[5]. After complete pulverization, the samples were extracted
Available data indicate that phosphate depletion (PD) mark-
edly affects cardiac and skeletal muscle function and metabo-
lism. Schneider and Steenbock [1] reported in 1939 that experi-
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Table 1. Effect of 4, 8, and 12 weeks of dietary phosphate restriction on the concentration of serum phosphorus and on intracellular
concentration of inorganic phosphorus, adenine nucleotides and creatine phosphate in skeletal musclea
Serum
phosphorus
mgldl
.
Body weight
grams
Inorganic
phosphorus ATP ADP AMP
Creatine
phosphate
moIesIg protein
Control 8.5 0.13 170.0 8.0 29.2 2.5 22.0 1.2 3.9 0.2 1.2 0.2 61.2 3.9
4-Week PD 5.0 0.4b 160.0 6.5 16.0 59b 26.5 4.7 4.4 1.0 1.1 0.2 73.0 13.0
Control 9.0 0.6 192.0 10.0 31.5 3.3 26.0 2.5 3.7 0.2 1.3 0.! 62.5 3.5
8-Week PD 4.3 0.5 175.0 12.0 21.0 2.lb 24.0 0.4 3.6 0.2 1.2 0.2 58.0 8.2
Control 9.0 0.4 220.0 11.5 34.0 3.5 27.7 3.3 4.1 0.6 1.0 0.1 53.8 3.3
12-Week PD 3.0 0.P' 190.0 12.5" 19.0 1.1" 25.5 1.0 5.2 0.8 0.8 0.1 64.0 7.6
Abbreviations: PD, phosphate depletion; ATP, adenosine triphosphate; ADP, adenosine diphosphate; AMP, adenosine monophosphate.
Data are presented as mean SE. Each number represents 12 to 14 rats.
Indicate significant difference from control of P < 0.01.
with 3 M perchloric acid at — 10°C to allow penetration and
fixation of the powder by the acid [5]. The solution was then
centrifuged, and the supernatant was removed and neutralized
with a small amount of saturated solution of K2C03. The
mixture was kept at 2°C for 15 mm, centrifuged, and the KCIO4
precipitate removed. The extract was processed using the
Bessman automatic phosphate analyzer which is, in principal,
high pressure liquid chromatography on an anion exchange
column for separation of phosphorylated intermediates, and
final ashing and colorimetric determinations upon completion of
the separation [6]. The method we used, described in brief, is as
follows: Separation of phosphorylated intermediates is accom-
plished by anion exchange on quaternary ammonium resins
with borate containing ammonium chloride buffers at pH values
of 8.5 to 9.0. Phosphate compounds in a typical sample applied
to the high pressure liquid chromatograph column are allowed
to bind to the water-washed resin. Washing with water is
continued to remove excess quantities of nonbound compounds
and cations.
All peaks of interest were identified both with internal
standards and co-chromatography with a known amount of
authentic compound. Recovery for individual metabolites was
evaluated utilizing measurements of known amounts of stan-
dard with and without the column, Since ionosine monophos-
phate (IMP) is present in very small amounts in normal and
adequately handled muscle tissue, and since IMP increases with
any degree of tissue hypoxemia due to inadequate processing of
the tissue, we examined each chromatographic run for IMP
peaks. No IMP peaks were detected suggesting adequate freez-
ing and processing of the samples.
Mitchondrial energy production. Mitochondria were isolated
utilizing a method described by Yang, Geiger, and Bessman [71.
Rats were sacrificed and skeletal muscle was washed out of
blood, placed in ice-cold homogenization medium containing
0.35 mtvt mannitol, 0.1 ma't EDTA, and 10 mM Iris-buffer at a
pH of 7.2. The tissue samples were then cut into small pieces
and run through a Harvard-tissue press. Since rat skeletal
muscle is resistant to mechanical homogenization, at this point
the tissue was treated for 30 mm with trypsin. At the end of 30
mm, a trypsin inhibitor was used to stop the reaction. The fine
tissue is then homogenized utilizing a Dounce-type homogeniz-
er. After final homogenization, the homogenate is then centri-
fuged for 10 mm at XSOOg in a refrigerated centrifuge. The
pellete is discarded and the supernatant centrifuged at x 8000g
for 10 mm for final isolation of mitochondria. The mitochondrial
pellete is washed several times and then suspended in a medium
containing (1) homogenization medium, (2) 0.5% (WIV) dia-
lyzed albumin, (3) 0.1 M tris-phosphate buffer pH 7.2. The
protein concentration of the mitochondrial pellete was deter-
mined utilizing a modification of the Lowry and Passanneau
method [5].
Substrate oxidation ratio and ADPIO ratios were determined
polarographically by means of a Clark oxygen electrode (Gilson
Electronics, Middleton, Wisconsin) fitted to a plexiglass cham-
ber of 2.0 ml capacity as described originally by Chance and
Williams [81. The complete system contained 1 mg mitochondri-
al protein added to 2 ml of incubation medium containing 50 mM
KCI, 25 mt tris-Hcl buffer (pH 7.4), 10 to 20 m potassium
phosphate buffer (pH 7.4), 8 mM MgCI2, 65 m sucrose, 20 mM
cytochrome C, 1 mivi NAD+, 0.5 mvi EDTA, and 0.05% bovine
serum albumin. Exogenous substrate used was a ketoglutarate
3.5 mM. The respiratory state of the mitochondria is defined
according to Chance and Williams [8]. The principle of this
methodology is based on the observation that when tightly
coupled mitochondria are suspended in an isotonic buffer, a
slow rate of oxygen uptake is measured in the presence of
substrate and absence of ADP. The addition of ADP will cause
an immediate increase in oxygen uptake dependent on the
concentration of ADP added to the reaction. The concentration
of oxygen uptake is related directly to the amount of ADP
phosphorylated to ATP. The ADP:O ratio which is equivalent
to P:O ratio can be calculated.
Mitochondrial energy transport. Assay for mitochondrial
creatine phosphokinase utilized the modification of a method
described by Oscai and Holloszy [91. The activity of creatine
phosphokinase is measured utilizing a system coupled with
pyruvate kinase and lactate dehydrogenase. The assay mixture
contains in the final volume of 1 ml: 50 moles of phosphoenol
pyruvate, 0.15 tmoles of NADH, and 50 mg of lactate dehy-
drogenase. The reaction starts by adding creatine; the oxidation
of NADH is followed spectrophotometrically.
Myofibrillar energy utilization. Myofibrils were isolated and
purified according to the method of Solaro, Panyg, and Briggs
[10]. Skeletal muscle tissue was trimmed of fat and homoge-
nized for 1 mm in 4 vol of a 0.3 M sucrose solution containing 10
mM imidazole (pH 7.0). The homogenate was centrifuged at
x17,300g for 20 mm. The pellete was then suspended in a
standard buffer solution containing 60 mrvi KCI, 30 msi imidaz-
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Table 1. (Continued)
Protein
Creatine
content
mg/g wet
weight
Phosphorylation
potential M
Energy
charge
Total
adenine
nucleotides
Hexokinase
lU/mg
protein
DNA
p.g/g
dry weight
2020 170
4160 102"
2000 330
3370 530b
0.889 0.05
0.867 0.07
0.862 0.02
0.893 0.07
27.5 1.4
32.0 2.0
31.0 2.8
28.6 0.9
63.6 4.1 272.0 21.0 2084 260 0.861 0.02 32.8 3.9 13.1 2.1 880.0 20.0
58.7 10.0 290.0 31.0 2830 l4tW 0.900 0.03 31.0 2.0 13.9 1.8 890.0 10.0
in our normal animals are in agreement with values reported by
others [15, 161. Dietary phosphate restriction was associated
with a significant (P < 0.01) and marked decrement in serum
concentration of phosphorus with the levels being lowest after
12 weeks of PD. A significant (P < 0.01) reduction in the
concentration of cellular inorganic phosphorus was evident afer
4 weeks of PD and remained low thereafter. There was a
significant (P < 0.01) and direct correlation between serum
levels of phosphorus and the concentration of inorganic phos-
• •• phorus in skeletal muscle (Fig. 1).
• Skeletal muscle concentrations of ATP, ADP, and AMP in
PD rats were not lower than those in control animals. There was
no correlation between the concentrations of these nucleotides
and the serum levels of phosphorus or the celluliir concentra-
tion of inorganic phosphorus. Phosphorylation potential was
elevated at 4 weeks of PD and remained elevated at 8 and 12
weeks of PD. Energy charge was maintained at normal levels
(Table 1). Skeletal muscle concentration of creatine and cre-
atine phosphate were not decreased with PD.
The effects of PD on various parameters of mitochondrial
function are given in Table 2. Respiratory control ratio (RC) and
ADP:O ratio were not affected by PD of up to 12 weeks. Uptake
of oxygen per unit time was significantly reduced (P < 0.01)
after 4, 8, and 12 weeks of PD. The activity of creatine
phosphokinase was significantly reduced after 4 weeks of PD
and fell further after 12 weeks of PD. The addition of creatine to
state four respiring mitochondria significantly enhanced oxygen
consumption in mitochondria from control but not from PD
animals as expressed by the ratio of oxygen consumption with
and without creatine.
The effects of PD on the activity of creatinine phosphokinase
of skeletal muscle myofibrils are shown in Table 3. There was a
significant and marked decline in the activity of the enzyme
which became apparent within 4 weeks of PD and remained
reduced throughout the study.
Total extractable creatine phosphokinase after 4 weeks of PD
was a value significantly lower (P <0.01) than normal (10.0
1.8 vs. 28.0 4.6 IU mg protein). There was a significant direct
correlation (P < 0.01) between total extractable creatine phos-
phokinase and cellular inorganic phosphorus levels (Fig. 2).
Results The concentration of hexokinase in PD rats was not signifi-
cantly different from normal pairfed controls (Table 1). There
was no significant difference in urinary creatine between normal
and PD rats. Urinary creatine ranged between 0.21 0.19 to
0.50 0.25 mg/day in PD rats and between 0.30 0.12 to 1.02
0.45 mg/day in normal animals during the first week of the
study. Values were 0.14 0.08 to 0.64 0.29 mg/day in PD rats
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Fig. 1. Correlation between skeletal muscle, cellular inorganic phos-
phorus, and serum phosphorus during 4, 8, and 12 weeks of phosphate
depletion.
•• •
R =0.54
N = 34
P<0.01
Y=7.6+2.5X
ole (pH 7.0), and 1.0 mrvi MgC12. This process of homogeniza-
tion, centrifugation, and resuspension was repeated four times.
The myofibrils were further purified by several washings with
standard buffer containing 1% Triton. The puriifed myofibrils
were then resuspended in standard buffer to a protein concen-
tration 8 to 10 mg/ml. The activity of creatine phosphokinase
was determined and expressed per milligram of protein. Total
cellular creatine phosphokinase was extracted utilizing a modi-
fication of the method described by Klein, Shell, and Sobel [11].
Cellular hexokinase activity was measured utilizing enzymat-
ic methods [12]. DNA was measured utilizing a modification of
the method described by Burton [13].
Twenty-four hour urine collections for the measurement of
creatine [14] were obtained from normal and PD rats housed in
metabolic cages. The collections were made daily during the
first and 12th weeks of the study.
The effects of various duration of PD on the serum concentra-
tion of phosphorus, body weight, tissue protein content, and on
the intracellular concentration of inorganic phosphorus, ade-
nine nucleotides, creatine phosphate, and creatine of skeletal
muscle are presented in Table 1. The levels of adenine nucleo-
tides, inorganic phosphorus, creatine phosphate, and creatine
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Table 2. Effects of 4, 8, and 12 weeks of phosphate depletion on mitochondrial functionsa
Oxygen
ADP:0
Respiratory
control
consumption
nmoleslmg
protein/mm
Creatine
phosphokinase
lU/mg protein
Oxygen consumption at
state 4+ creatine!
without creatine
Control 3.7 0.20 7.24 0.6 170.4 7.0 2.85 0.22 1.60 0.07
4-Week PD 3.9 0.12 8.6 0.6 131.0 15.Ob 1.33 0.l5' 1.20 0.98b
Control 3.6 0.20 8.4 0.3 177.0 9.3 2.45 0.17 1.61 0.08
8-Week PD 3.7 0.20 7.8 0.9 80.5 8.lb 1.07 0.08b 1.10 O.04b
Control 3.6 0.11 5.1 0.5 178.0 8.5 2.60 0.20 1.57 0.07
12-Week PD 3.3 0.25 4.2 0.5 82.0 12.0" 1.10 0.10" 1.02 0.03"
Data are presented as mean SE. Each number represents 12 to 14 rats.
b Indicate statistical significant difference from control at P < 0.01.
Table 3. Effects of phosphate depletion on myofibrillar creatine
phosphokinase activitya
Number
of rats
Normal
phosphate
Phosphate depletion
4 weeks 12 weeks
1 0.360 0.150 0.291
2 0.440 0.210 0.293
3 0.420 0.350 0.313
4 0.460 0.193 0.150
5 0.340 0.261 0.230
Mean
SE 0.018 0.015
Each point represents one animal. Results are expressed as interna-
tional units per milligram of protein per minute.
bThe value is significantly different from normal, P < 0.01.
and 0.53 0.26 to 2.01 0.45 mg/day in normal animals during
the 12th week of the study. Thus, PD was not associated with
creatinuria.
Discussion
Our study examined the effects of PD on the various steps of
energy metabolism, utilizing both static biopsy values of inor-
ganic phosphorus, adenine nucleotides, and creatine phosphate
and dynamic mitochondrial oxiclative phosphorylation as well
as mitochondrial energy transport and utilizing via the creatine
phosphate-creatine phosphokinase energy shuttle. The results
demonstrated that dietary phosphate restriction in the rat is
associated with marked alterations in the various steps of
energy metabolism.
It is accepted that only a small portion of the total ATP is
available for muscle contraction and subsequent replenishment
via creatine phosphokinase [17, 18], the contractile myofibrills
are coupled to the rephosphorylation of ADP via creatine
phosphokinase, and creatine is the effector molecule in the
feedback control of energy production in muscle [19, 20]. The
compartmentation of the adenine nucleotides has been the basis
for the shuttle system in which creatine phosphate transports
energy. The features of this system include: (1) The availability
of large concentrations of creatine phosphate [21]; (2) high
activity of creatine phosphokinase at the mitochondria and
myofibrills [22, 15]; and (3) specificity of creatine phosphate
and creatine to the creatine phosphokinase reaction, in contrast
to the many available adenine nucleotides utilizing reactions
[161.
Our findings of reduced mitochondrial oxygen consumption
and phosphorylation point toward an impairment in mitochon-
drial energy production. The reduced mitochondrial creatine
phosphokinase activity, together with inability to increase
maximally oxygen consumption at State 4 (ATP saturation with
creatine) are compatible with a defect in transport of energy in
the form of ATP from the inner mitochondrial compartment to
the outer mitochondrial membrane via the reaction: ATP +
creatine CPK creatine phosphate + ADP. Finally, the impair-
ment in the activity of myofibrillar creatine phosphokinase
isoenzyme is consistent with reduced energy utilization since
the myofibrillar isoenzyme catalyzes the reaction: ADP +
creatine phosphate CPKATP + creatine. Thus, all steps of
skeletal muscle cellular energetics are impaired in PD.
The cellular levels of ATP and creatine phosphate were
unaltered. These findings are in contrast to our observation of a
reduced ATP and creatine phosphate levels in the myocardium
of PD rats [4]. This difference could be attributed to the level of
activity of the skeletal and heart muscle. The rats are less active
and are sluggish in their movement, and energy need for
skeletal muscle activity is reduced. The decreased production
may meet these reduced needs and in turn the ATP and creatine
phosphate pools are not reduced. In contrast, the heart main-
tains continuous activity and the energy needs exceeds energy
production, resulting in the fall of the content of high energy
compounds.
The observation that creatine phosphokinase isoenzymes
both at the mitochondria and myofibrillar compartments were
reduced, does not necessarily mean that PD specifically affects
these enzymes. It could be argued that PD causes a reduction in
protein synthesis and this in turn will cause a reduction in the
activity of many enzymes. However, hexokinase, another
enzyme which is abundant in both cell cytosol and mitochon-
dna, was not affected by PD, and protein, as well as DNA
content (Table 1) was not different in skeletal muscle from
normal and PD rats suggesting that the reduction in the creatine
kinase isoenzyme is rather specific. Since mitochondrial and
myofibrillar isolations could be accompanied by loss of bound
creatine phosphokinase, it could be argued that the reduction in
the activity is the result of mechanical loss of the enzyme
secondary to the isolation. This is unlikely since total extract-
able creatine phosphokinase activity was markedly reduced
further demonstrating a direct effect on PD on cellular creatine
phosphokinase isoenzymes.
The mechanism by which PD may alter the activity of
creatine phosphokinase isoenzyme is not known. It is interest-
ing that the changes in cellular activity of creatine phosphoki-
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Fig. 2. Correlation between cellular extractable creatine phosphokinase
and cellular inorganic phosphorus.
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isoenzyme may be the key biochemical disturbance in the
myopathy of phosphate depletion.
